Sunil Healthcare Limited (BOM:537253)

India flag India · Delayed Price · Currency is INR
63.00
-4.00 (-5.97%)
At close: Mar 9, 2026
-9.08%
Market Cap 646.05M
Revenue (ttm) 892.01M
Net Income (ttm) 28.53M
Shares Out 10.25M
EPS (ttm) 2.78
PE Ratio 22.67
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 114
Average Volume 448
Open 70.00
Previous Close 67.00
Day's Range 61.55 - 70.00
52-Week Range 60.55 - 88.70
Beta -0.29
RSI 42.24
Earnings Date May 26, 2026

About Sunil Healthcare

Sunil Healthcare Limited engages in the manufacture and sale of empty hard gelatin, hydroxypropyl methylcellulose (HPMC), and pullulan capsules shells in India and internationally. Its products include EHG, BSE/TSE free, pearl, liquid fill, preservative free, stick free, flavored, SLS free, natural color, non-AZO, gelatin, HPMC/vegetable, and pullulan capsules. The company also provides ayurvedic products, such as haldi, ginger, vasaka, trifala, guduchi, salaki, punarvana, shatavari, hadjod, hingwastak, mulethi, arjuna, ashwagandha, and guggul ... [Read more]

Industry Miscellaneous Chemical Products
Founded 1973
Employees 161
Stock Exchange Bombay Stock Exchange
Ticker Symbol 537253
Full Company Profile

Financial Performance

In fiscal year 2025, Sunil Healthcare's revenue was 834.21 million, a decrease of -7.51% compared to the previous year's 901.92 million. Losses were -14.17 million, -20.79% less than in 2024.

Financial Statements

News

There is no news available yet.